Live Markets »News & Advice»Company News»Company News Details
Company News Details

Lupin gets USFDA nod for contraceptive tablet 'Tydemy' for women

Press Trust of India/New Delhi 13 Mar 18 | 04:15 PM

An employee of Lupin Limited works at a reception at their headquarters in Mumbai

Pharma major Lupin today said it has launched its Tydemy tablets, indicated for use by women to prevent pregnancy, in the US.

Related Stories

    No Related Stories Found
Widgets Magazine

The launch follows the approval from the US Food and Drug Administration (USFDA) of Tydemy tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg), the company said in a statement.

The approved Tydemy tablets are generic equivalents of Bayer HealthCare Pharmaceuticals Inc's Safyral tablets, Lupin said.

The medicine is indicated for use by women to prevent pregnancy and to raise folate levels in women who choose to use an oral contraceptive for contraception, it added.

Widgets Magazine


Company Price Gain (%)
Sun Pharma.Inds.576.303.91
M & M908.152.78
H D F C1,902.402.54
Axis Bank524.652.22
Bharti Airtel374.601.74


Currently No Poll Available.

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine